BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25713023)

  • 21. Association Between Educational Level and Risk of Cancer in HIV-infected Individuals and the Background Population: Population-based Cohort Study 1995-2011.
    Legarth R; Omland LH; Dalton SO; Kronborg G; Larsen CS; Pedersen C; Pedersen G; Gerstoft J; Obel N
    J Infect Dis; 2015 Nov; 212(10):1552-62. PubMed ID: 25904603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening colonoscopy for the detection of neoplastic lesions in asymptomatic HIV-infected subjects.
    Bini EJ; Green B; Poles MA
    Gut; 2009 Aug; 58(8):1129-34. PubMed ID: 19293177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.
    Bedimo RJ; McGinnis KA; Dunlap M; Rodriguez-Barradas MC; Justice AC
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):203-8. PubMed ID: 19617846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals.
    Suneja G; Shiels MS; Melville SK; Williams MA; Rengan R; Engels EA
    AIDS; 2013 Jan; 27(3):459-68. PubMed ID: 23079809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area.
    Castel AD; Young H; Akiwumi AM; Vargas A; Rogers K; West T; Levine PH
    AIDS Care; 2015; 27(7):860-9. PubMed ID: 25714364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μl.
    Kong CY; Sigel K; Criss SD; Sheehan DF; Triplette M; Silverberg MJ; Henschke CI; Justice A; Braithwaite RS; Wisnivesky J; Crothers K
    AIDS; 2018 Jun; 32(10):1333-1342. PubMed ID: 29683843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults.
    Althoff KN; McGinnis KA; Wyatt CM; Freiberg MS; Gilbert C; Oursler KK; Rimland D; Rodriguez-Barradas MC; Dubrow R; Park LS; Skanderson M; Shiels MS; Gange SJ; Gebo KA; Justice AC;
    Clin Infect Dis; 2015 Feb; 60(4):627-38. PubMed ID: 25362204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.
    Silverberg MJ; Lau B; Justice AC; Engels E; Gill MJ; Goedert JJ; Kirk GD; D'Souza G; Bosch RJ; Brooks JT; Napravnik S; Hessol NA; Jacobson LP; Kitahata MM; Klein MB; Moore RD; Rodriguez B; Rourke SB; Saag MS; Sterling TR; Gebo KA; Press N; Martin JN; Dubrow R;
    Clin Infect Dis; 2012 Apr; 54(7):1026-34. PubMed ID: 22291097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012.
    Djawe K; Buchacz K; Hsu L; Chen MJ; Selik RM; Rose C; Williams T; Brooks JT; Schwarcz S
    J Infect Dis; 2015 Nov; 212(9):1366-75. PubMed ID: 26044289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality and its predictors among highly active antiretroviral therapy naive hiv-infected individuals: data from prospective cohort study in Ukraine.
    Zhyvytsia D
    Georgian Med News; 2014; (232-233):69-74. PubMed ID: 25214276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excess Mortality among HIV-Infected Individuals with Cancer in the United States.
    Coghill AE; Pfeiffer RM; Shiels MS; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1027-1033. PubMed ID: 28619832
    [No Abstract]   [Full Text] [Related]  

  • 33. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study.
    Mbulaiteye SM; Katabira ET; Wabinga H; Parkin DM; Virgo P; Ochai R; Workneh M; Coutinho A; Engels EA
    Int J Cancer; 2006 Feb; 118(4):985-90. PubMed ID: 16106415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals.
    Marcus JL; Leyden WA; Chao CR; Horberg MA; Klein DB; Quesenberry CP; Towner WJ; Silverberg MJ
    AIDS; 2017 Apr; 31(7):989-993. PubMed ID: 28252529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer risk among the HIV-infected elderly in the United States.
    Yanik EL; Katki HA; Engels EA
    AIDS; 2016 Jun; 30(10):1663-8. PubMed ID: 26950314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Thiessard F; Morlat P; Marimoutou C; Labouyrie E; Ragnaud JM; Pellegrin JL; Dupon M; Dabis F
    Cancer; 2000 Apr; 88(7):1696-702. PubMed ID: 10738229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of anal human papillomavirus infection and cytologic abnormalities among HIV-infected and HIV-uninfected men who have sex with men.
    Latini A; Dona MG; Ronchetti L; Giglio A; Moretto D; Colafigli M; Laquintana V; Frasca M; Zaccarelli M; Antinori A; Cristaudo A; Giuliani M
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19662. PubMed ID: 25397412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer in HIV infected patients: facts, questions and challenges.
    Cadranel J; Garfield D; Lavolé A; Wislez M; Milleron B; Mayaud C
    Thorax; 2006 Nov; 61(11):1000-8. PubMed ID: 17071836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.
    Harboe ZB; Larsen MV; Ladelund S; Kronborg G; Konradsen HB; Gerstoft J; Larsen CS; Pedersen C; Pedersen G; Obel N; Benfield T
    Clin Infect Dis; 2014 Oct; 59(8):1168-76. PubMed ID: 25038114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.